1. ReportLinker Data
  2. Life Sciences
  3. Pharmaceutical
  4. Pharmaceutical Exports
  5. Export of Penicillins or…

Export of penicillins or streptomycins not in dosage forms from Europe: Decline in 2017

United Nations Statistical Office published that in comparison with the prior year the indicator greatly decreased by 33.39%. The variable dropped sharply from 1 677 583 kilogram to 1 117 513.25 kilogram, as it follows the tendency of the previous year when it went down by 20.73%. The overall changes for the prior 18 years hit a decrease of 44.25%. As well as it has attained a drop at a 0.16% CAGR over the 5 years with a modest overall raise since the start of time series. It averaged 1 686 083.57 kilogram from 2000 to 2017 and it reached its all-time high of 3 565 916 kilogram in 2014 and record low of 814 860 kilogram in 2009.

Export of penicillins or streptomycins not in dosage forms from Europe: Decline in 2017
Date Kilogram Variation
2017 1 117 513.25 -33.39
2016 1 677 583.00 -20.73
2015 2 116 330.00 -40.65
2014 3 565 916.00 35.5
2013 2 631 604.00 90.89
2012 1 378 624.00 47.73
2011 933 224.00 -15.77
2010 1 107 914.00 35.96
2009 814 860.00 -29.72
2008 1 159 430.00 -33.37

Related Statistics

Pharmaceutical Exports in other Countries

Main Pharmaceutical Indicators

  • Pharmaceutical Imports

  • Pharmaceutical Exports

  • Medicine Use

    Use of medicines, usually meadured in in defined daily dosis (DDD) per day. The DDD consists of the assumed average maintenance dose per day for a drug used for its main indication in adults. Based on: World Health Organization.

  • Pharmaceutical Production

    Manufacture of basic pharmaceutical products and pharmaceutical preparations in million units of national currency or in volume index of production.

  • Pharmacist Density

  • Spending On Medicines

    Measures total value of spending on prescription medicines and insulins by retail pharmacies, hospitals, and other institutional pharmacies at invoice prices.

  • Re-Imbursed Pharmaceutical

    Share of re-imbursed medication in the pharmaceutical market, usually expressed in percentage of medication sales or in value of reimbursements (thousands or millions of national currency). It can be measured separately for generic medication and brand-name medication, or for the whole market. Based on: Organisation for Economic Co-operation and Development.

  • Pharmaceutical Registrations

  • Pharmaceutical Revenue

    Revenue of pharmaceutical industry. The latter is comprised of companies engaged in researching, developing, manufacturing and distributing drugs for human or veterinary use. Based on: United States Department of Commerce.

  • Drug Store Retail Sales